Acute myeloid leukemia cell therapy by combining MR1-modulating drugs and MR1 T cells
Blood Immunology & Cellular Therapy
· Elsevier
Аннотация
Publication date: September 2026 Source: Blood Immunology & Cellular Therapy, Volume 2, Issue 3 Author(s): Natalie Kehrer, Aisha Beshirova, Daniel Constantin, Vladimir Nosi, Marco Stringhini, Marine Cordonnier, Verena Schaefer, Giulia Montanelli, Andrew Chancellor, Alexander Tzankov, Katja Seipel, Raphael Battegay, Thomas Pabst, Jakob Passweg, Martin Carroll, Alessandro Vacchini, Lucia Mori, Jürg Schwaller, Gennaro De Libero
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Медицина»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Acute myeloid leukemia cell therapy by combining MR1-modulating drugs and MR1 T cells. // Blood Immunology & Cellular Therapy. – URL: https://www.sciencedirect.com/science/article/pii/S3050597626000436?dgcid=rss_sd_all
Acute myeloid leukemia cell therapy by combining MR1-modulating drugs and MR1 T cells. Blood Immunology & Cellular Therapy. https://www.sciencedirect.com/science/article/pii/S3050597626000436?dgcid=rss_sd_all
“Acute myeloid leukemia cell therapy by combining MR1-modulating drugs and MR1 T cells.” Blood Immunology & Cellular Therapy.
@article{article38476,
title = {Acute myeloid leukemia cell therapy by combining MR1-modulating drugs and MR1 T cells},
journal = {Blood Immunology \& Cellular Therapy},
url = {https://www.sciencedirect.com/science/article/pii/S3050597626000436?dgcid=rss_sd_all}
}